New eye drop could ease severe allergy symptoms in kids and adults

This study tests whether adding diquafosol eye drops to standard treatment helps people with moderate-to-severe vernal keratoconjunctivitis (a serious eye allergy). About 94 participants aged 6 and older will receive either diquafosol plus cyclosporine or cyclosporine alone. Researchers will check eye health, symptoms, and quality of life over 16 weeks.